Saturday 6 March 2021 ,
Saturday 6 March 2021 ,
Latest News
  • 3rd Dash-8 aircraft “Shwetbalaka” reaches Dhaka
  • PM ensures communal harmony in country: Palak
  • Bangladesh elected Int’l Seabed Authority council member
  • Bangladesh team safe in New Zealand
  • Three HuJI militants remanded
  • NBR honours Kaus Mia as best taxpayer of Mujib Year
  • Covid-19 in Bangladesh: Daily infection rate rises, 6 more die
  • Virus kills fewer African women than men: WHO study
  • Jaishankar wraps up brief visit reaffirming robust Dhaka-Delhi ties
  • Bangladesh reports six COVID-19 deaths, 5,01,144 total recoveries
  • “You’ll see in a few days,” says Anisul on amending DSA
  • Bangladesh reports six COVID-19 deaths, 5,01,144 total recoveries
18 January, 2021 12:31:04 PM / LAST MODIFIED: 18 January, 2021 02:32:14 PM
Print

India confirms 447 cases of adverse events following Covid-19 vaccination

Xinhua, New Delhi
India confirms 447 cases of adverse events following Covid-19 vaccination
A healthcare worker reacts as she receives a dose of COVISHIELD, a Covid-19 vaccine manufactured by Serum Institute of India, during vaccination campaigns at Mathalput Community Health Centre in Koraput district of India. Photo: Collected

A total of 447 cases of Adverse Event Following Immunization (AEFIs) after the COVID-19 vaccination have been reported over the past two days, out of whom three required hospitalization, India's health ministry said on Sunday.

"Of those who were hospitalised, one was discharged from the Northern Railway Hospital in Delhi within 24 hours, one another was discharged from the All-India Institute of Medical Sciences (AIIMS) in Delhi, and one is still under observation in AIIMS in Rishikesh (northern state of Uttarakhand) and is being monitored," said a statement issued by the ministry.

Most of the AEFIs reported so far included minor ailments like fever, headache and nausea etc.

Till Sunday a total of 224,301 beneficiaries have been vaccinated, out of whom 17,072 beneficiaries were vaccinated on Sunday alone.

The second day of the countrywide COVID-19 vaccination program was conducted with 553 sessions held in six states.

An AEFI is any unexpected medical occurrence following immunization which may not be related to vaccine or vaccination process. Protocols are in place for reporting, immediate case management at vaccination session site, transportation and hospitalization and further care of such cases.

According to health ministry officials, protocols are also in place for systematic investigation and causality assessment of serious AEFIs.

All the Indian states have been advised to plan COVID-19 vaccination sessions four days in a week to minimize disruption of the routine health services. Some states have already publicised their weekly vaccination days.

Two types of COVID-19 vaccines were supplied for the vaccination drive. While the "Covishield" vaccine, made by the Serum Institute of India, was supplied to all the Indian states, the "Covaxin" vaccine, made by Bharat Biotech International Limited, was supplied to 12 states.

TH

 

Comments

Video

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting